“…Despite the striking adaptability of Schwann cells to damage, the clinical outcomes of human patients generally exhibit only partial recovery in many cases (Höke, 2006;Lundborg, 2000). One of the main reasons is that axons must regenerate over a relatively long distance, and Schwann cells more distal to injury sites gradually lose their ability to foster nerve regeneration (Jonsson et al, 2013;Ronchi et al, 2017;Sulaiman & Gordon, 2009;Sulaiman & Gordon, 2013), which could be in part due to reduced expression of neurotrophic factors like GDNF and BDNF (Eggers, Tannemaat, Ehlert, & Verhaagen, 2010;Fontana et al, 2012;Höke, Gordon, Zochodne, & Sulaiman, 2002;Li, Terenghi, & Hall, 1997;Michalski, Bain, & Fahnestock, 2008;Sulaiman & Gordon, 2009). Therefore, identifying the molecular mechanisms that enable rapid axon regeneration is important for improving therapeutic strategies for peripheral nerve damage.…”